DE MOTU CORDIS
LIVE

Serial Number

79362794

Owner

De Motu Cordis Pty Ltd

Attorney

John Pickerill

Filing Date

Dec 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DE MOTU CORDIS Trademark

Serial Number: 79362794 • Registration: 7416380

DE MOTU CORDIS is a trademark filed by De Motu Cordis Pty Ltd on December 20, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

De Motu Cordis Pty Ltd (3 trademarks)

Floor 1, Unit 9,

Entity Type: 99

Trademark Details

Filing Date

December 20, 2022

Registration Date

June 18, 2024

Published for Opposition

April 2, 2024

Goods & Services

Medical, clinical, scientific and technological research services and new product design relating thereto in the emergency medicine field; medical and scientific research, namely, conducting clinical trials for others; product design and development of medical emergency treatment solutions; design and development of medical devices; product development; scientific and medical research to develop new products; Software as a Service (SaaS) service featuring non-downloadable software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; provision of online non-downloadable software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; provision of online non-downloadable software for use in assisting with medical emergencies, for providing clinical guidance, for providing medical information, and for medical and education training purposes featuring instruction in medicine; provision of online non-downloadable software for providing clinical guidance; provision of online non-downloadable software providing medical information; provision of online non-downloadable software for medical education and training purposes featuring instruction in medicine; hosting an online website for the provision of medical information; hosting an online website for the provision of medical education and training services

Medical apparatus for use in emergency treatment of life threatening conditions; medical devices for use in emergency treatment of life threatening conditions; inhalers for medical use, sold empty; medical inhalers sold empty and medical inhaler devices provided empty for administering pharmaceuticals; drug delivery apparatus and devices, namely, inhalers for the treatment of anaphylactic reactions and cardiac conditions, sold empty; medical apparatus, namely inhalers, for administering drugs into the lungs, sold empty; apparatus provided empty used for the inhalation of pharmaceutical preparations; filters for inhalers for medical purposes

Medical services; emergency medical services; telemedicine services; emergency medical services regarding anaphylactic reactions and cardiac conditions; provision of medical information regarding emergency health care including in relation to anaphylactic reactions and cardiac conditions; health care medical consultancy services; provision of medical information; provision of medical information including regarding anaphylactic reactions and cardiac conditions

Pharmaceutical preparations and substances in the field of emergency medicine for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations and substances for the treatment of anaphylactic reactions; pharmaceutical preparations and substances for treatment of cardiac conditions; pharmaceutical preparations and substances for treatment of heart diseases; pharmaceutical preparations for the treatment of diabetes; glucose for medical purposes; glucose in the form of pharmaceutical products, namely glucose pharmaceutical preparation for medical purposes; glucose powder for medical purposes; inhalants, namely, inhalant pharmaceutical preparations for the treatment of anaphylactic reactions and cardiac conditions; drugs to be administered by inhalation, namely, inhalant pharmaceutical for the treatment of anaphylactic reactions and cardiac conditions; pharmaceutical preparations to be inhaled for the treatment of anaphylactic reactions and cardiac conditions

Downloadable computer software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; downloadable application software for data collection and management, automated calling, location tracking and sharing, and for providing information, clinical guidance and medical education and training featuring instruction in medicine for medical and health care purposes, for use in assisting with medical emergencies; downloadable application software for use in medical emergencies, for providing clinical guidance, for providing medical information and for medical education and training purposes featuring instruction in medicine; downloadable application software for providing clinical guidance; downloadable application software providing medical information; downloadable application software for medical education and training purposes featuring instruction in medicine, emergency medicine and treatment of life threatening conditions; downloadable global positioning systems (GPS) software for tracking and mapping geospatial data; downloadable electronic publications in the nature of journals, information sheets, brochures, newsletters, and instruction manuals providing medical information; downloadable electronic publications in the nature of journals, information sheets, brochures, newsletters and instruction manuals in the field of medical education and training

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 14, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 27, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 27, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 18, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 16, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 14, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 14, 2024 ERFR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Jan 26, 2024 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Jan 26, 2024 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Jan 26, 2024 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 23, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 14, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 14, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 14, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 23, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 22, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 16, 2023 REPR